NASDAQ:EKSO Ekso Bionics (EKSO) Stock Price, News & Analysis $3.50 +0.15 (+4.33%) As of 03:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Ekso Bionics Stock (NASDAQ:EKSO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Ekso Bionics alerts:Sign Up Key Stats Today's Range$3.35▼$3.4950-Day Range$2.82▼$4.8252-Week Range$2.73▼$19.20Volume27,246 shsAverage Volume140,614 shsMarket Capitalization$9.13 millionP/E RatioN/ADividend YieldN/APrice Target$562.50Consensus RatingBuy Company Overview Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California. Read More Ekso Bionics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks37th Percentile Overall ScoreEKSO MarketRank™: Ekso Bionics scored higher than 37% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingEkso Bionics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEkso Bionics has received no research coverage in the past 90 days.Read more about Ekso Bionics' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Ekso Bionics are expected to grow in the coming year, from ($0.48) to ($0.15) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Ekso Bionics is -0.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Ekso Bionics is -0.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEkso Bionics has a P/B Ratio of 0.82. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Ekso Bionics' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.54% of the float of Ekso Bionics has been sold short.Short Interest Ratio / Days to CoverEkso Bionics has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Ekso Bionics has recently increased by 101.99%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEkso Bionics does not currently pay a dividend.Dividend GrowthEkso Bionics does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.54% of the float of Ekso Bionics has been sold short.Short Interest Ratio / Days to CoverEkso Bionics has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Ekso Bionics has recently increased by 101.99%, indicating that investor sentiment is decreasing significantly. News and Social Media0.6 / 5News SentimentN/A News SentimentEkso Bionics has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.Search InterestOnly 2 people have searched for EKSO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Ekso Bionics to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Ekso Bionics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.00% of the stock of Ekso Bionics is held by insiders.Percentage Held by InstitutionsOnly 6.42% of the stock of Ekso Bionics is held by institutions.Read more about Ekso Bionics' insider trading history. Receive EKSO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter. Email Address EKSO Stock News HeadlinesHC Wainwright Predicts Increased Earnings for Ekso BionicsAugust 12, 2025 | americanbankingnews.comEkso Bionics Holdings Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues LagJuly 30, 2025 | finance.yahoo.comGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly income to cover housing, healthcare, food, and fun... With a fraction of what you probably think you need.August 22 at 2:00 AM | Investors Alley (Ad)Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial ResultsJuly 30, 2025 | finanznachrichten.deEkso Bionics Holdings, Inc. (EKSO) Q2 2025 Earnings Call TranscriptJuly 28, 2025 | seekingalpha.comEkso Bionics outlines AI-powered rehabilitation push as personal health revenues grow 50% amid temporary enterprise sales delaysJuly 28, 2025 | msn.comEkso Revenue Falls 58 Percent in Q2July 28, 2025 | fool.comEkso Bionics Reports Second Quarter 2025 Financial ResultsJuly 28, 2025 | globenewswire.comSee More Headlines EKSO Stock Analysis - Frequently Asked Questions How have EKSO shares performed this year? Ekso Bionics' stock was trading at $137.25 on January 1st, 2025. Since then, EKSO shares have decreased by 97.5% and is now trading at $3.44. How were Ekso Bionics' earnings last quarter? Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) issued its quarterly earnings results on Monday, July, 28th. The company reported ($1.24) EPS for the quarter, missing analysts' consensus estimates of ($1.20) by $0.04. The firm earned $2.06 million during the quarter, compared to the consensus estimate of $4.31 million. Ekso Bionics had a negative net margin of 75.66% and a negative trailing twelve-month return on equity of 86.60%. Read the conference call transcript. When did Ekso Bionics' stock split? Ekso Bionics shares reverse split on the morning of Tuesday, May 27th 2025.The 1-15 reverse split was announced on Monday, May 19th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 26th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. Who are Ekso Bionics' major shareholders? Ekso Bionics' top institutional shareholders include Cresset Asset Management LLC (0.69%) and Geode Capital Management LLC (0.46%). Insiders that own company stock include Steven Sherman, Scott G Davis, Jerome Wong and Jason C Jones. View institutional ownership trends. How do I buy shares of Ekso Bionics? Shares of EKSO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Ekso Bionics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ekso Bionics investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), TransEnterix (TRXDW), Meta Platforms (META), Tesla (TSLA), Editas Medicine (EDIT) and Micron Technology (MU). Company Calendar Last Earnings7/28/2025Today8/22/2025Next Earnings (Estimated)10/27/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMachinery Current SymbolNASDAQ:EKSO Previous SymbolOTCMKTS:EKSOD CIK1549084 Webwww.eksobionics.com Phone(510) 984-1761Fax510-927-2647Employees60Year FoundedN/APrice Target and Rating Average Price Target for Ekso Bionics$562.50 High Price Target$900.00 Low Price Target$225.00 Potential Upside/Downside+16,691.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($6.64) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$11.33 million Net Margins-75.66% Pretax Margin-75.66% Return on Equity-86.60% Return on Assets-41.70% Debt Debt-to-Equity Ratio0.31 Current Ratio2.38 Quick Ratio1.57 Sales & Book Value Annual Sales$14.65 million Price / Sales0.60 Cash FlowN/A Price / Cash FlowN/A Book Value$4.18 per share Price / Book0.80Miscellaneous Outstanding Shares2,612,000Free Float2,455,000Market Cap$8.75 million OptionableOptionable Beta0.89 Social Links Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (NASDAQ:EKSO) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ekso Bionics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ekso Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.